Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Nirwana Health vs Voxy

Nirwana Health
Graded #192

Higher grade

vs+4.300000000000004
Voxy
Graded #280

Lower grade

The verdict

Nirwana Health takes it — 66.4/100 to 62.1/100.

Nirwana Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Nirwana Health (nirwanahealth.com) is a telehealth service offering compounded GLP-1 weight loss plus hair, sexual-wellness, and longevity care through licensed providers.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNirwana Health +20
70
50
Dose & formulationNirwana Health +11
75
64
Clinical oversightVoxy +5
77
82
Labs & monitoringVoxy +11
52
63
FulfillmentVoxy +11
67
78
Contract termsNirwana Health +13
33
20
Nirwana Health · left barVoxy · right bar

The numbers

MetricNirwana HealthVoxy
WeighScore66.4/10062.1/100
GradeCC
Scorecard rank#192#280
Semaglutide$149/mo (compounded)$179/mo (compounded)
Tirzepatide$229/mo (compounded)$299/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Nirwana Health

Graded #192 · C

Strengths

  • Offers compounded semaglutide and tirzepatide as both weekly injections and oral tablets
  • Transparent, published pricing with month-to-month, quarterly, and 6-month plans and no membership fee
  • Multi-month plans cut the per-month cost sharply (semaglutide as low as $99/mo, tirzepatide as low as $133/mo)
  • Advertises a $50-off code (LOOSE50) and covers weight loss plus hair, sexual-wellness, and longevity care
  • Also lists a retatrutide option and custom dosing plans for higher needs

Where it loses points

  • Prescribing medical group and compounding pharmacy are not named on the site
  • States of operation are not published; confirm eligibility during intake
  • Says it is 'LegitScript certified' but no verifiable seal is shown, so the claim is unconfirmed
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
Voxy

Graded #280 · C

Strengths

  • Names both its compounding pharmacy (VialsRX, Houston TX) and its prescribing medical group (Arora Health & Aesthetics) — most name neither
  • Publishes the full price ladder for both drugs across 1-, 3-, 6- and 12-month terms before you start the assessment
  • One price covers the provider visit, medication, injection supplies, shipping and monthly check-ins — no separate membership fee
  • True month-to-month option at $179 semaglutide / $299 tirzepatide with no commitment required
  • Free assessment with no charge to see if you qualify, and no labs required to start

Where it loses points

  • No terms of service anywhere on the site — /terms, /terms-of-service and /terms-of-use all return 404
  • No refund policy published; the only stated commitment language is 'cancel anytime'
  • Advertised 'Starting at $129/mo' is the 12-month prepay rate — month-to-month is $179 semaglutide and $299 tirzepatide
  • No public list of states served; availability depends on where affiliated providers are licensed
  • The prescribing nurse practitioner is not named — 'provider details available during your consultation'

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard